Filter Results
:
(140)
Show Results For
-
All HBS Web
(334)
- People (1)
- News (131)
- Research (140)
- Multimedia (13)
- Faculty Publications (84)
Show Results For
-
All HBS Web
(334)
- People (1)
- News (131)
- Research (140)
- Multimedia (13)
- Faculty Publications (84)
Sort by
- 20 Jan 2022
- Op-Ed
3 Steps to Help Companies Rebuild Trust During the Pandemic
We’re approaching year three of the COVID-19 pandemic, with no clear end in sight. During this time, companies have had to make difficult decisions about whether employees should work from home, wear masks in the office, and get View Details
Keywords:
by Sandra J. Sucher and Shalene Gupta
- 14 Apr 2022
- Op-Ed
Let’s Move Forward from COVID—Without Forgetting What We’ve Learned
environmental factors created by a persistent virus. It’s as if the success and gains made in 2021 with vaccinations and the incremental return to work and school policies have made leaders at different echelons reluctant to admit that...
View Details
Keywords:
by Hise O. Gibson and MaShon Wilson
- 19 May 2021
- Op-Ed
Why America Needs a Better Bridge Between School and Career
Over a year into the COVID-19 pandemic, there are hints of optimism as more people gain access to vaccines and the federal government injects more stimulus money into the economy. Yet, the outlook for workers remains mixed. The crisis has...
View Details
Keywords:
by Joseph B. Fuller and Rachel Lipson
- 19 Jul 2017
- Research & Ideas
Why Government 'Nudges' Motivate Good Citizen Behavior
other categories. A nudge on energy conservation that compared households to their neighbors led to almost twice as many kilowatt-hours saved per dollar spent as traditional education and incentives. A nudge to schedule flu shots led to almost a 50 percent increase in...
View Details
Keywords:
by Michael Blanding
- 13 Sep 2021
- Research & Ideas
Science: The Unlikely Frontier for New Business Ideas
operations after a year of uncertainty due to COVID-19, Krieger points to the science labs that never stopped—and some that worked overtime, such as companies like Moderna that produced vaccines in record time. He sees lots more...
View Details
Keywords:
by Avery Forman
- 13 Jan 2021
- Research & Ideas
How 'Small C' Change Can Beat Large-Scale Rebuilding
Even as COVID vaccines begin early deployment, pressure on leaders continues to mount to engage in “Big C” change: rapid course corrections through job cuts, recruiting a fresh management team, and redesigning roles and responsibilities...
View Details
- 04 Apr 2022
- Research & Ideas
Tech Hubs: How Software Brought Talent and Prosperity to New Cities
period. Software is penetrating other industries, Kerr notes. Take vaccines. Pharmaceutical companies’ speedy development of mRNA-based vaccines for COVID-19 required software, he notes. “Their capacity to bring a substantial software, AI...
View Details
Keywords:
by Rachel Layne
- 14 Dec 2020
- Research & Ideas
What Does December's Drug-Approval Dash Mean for COVID-19 Vaccines?
Pharmaceutical regulators around the world tend to speed through drug applications in December and before major national holidays, according to new research that might raise questions about COVID-19 vaccines and other treatments under...
View Details
- 09 Sep 2014
- First Look
First Look: September 9
patient. Schrader and his colleagues had to decide on which vaccines to focus and whether and how to target the drug companies that manufactured the vaccines or the quasi-government organizations (such as...
View Details
Keywords:
Sean Silverthorne
- 19 Jan 2022
- In Practice
7 Trends to Watch in 2022
As 2022 gets underway we asked our faculty to highlight some trends worth watching in the coming year. Ariel Stern: A new future for digital health care While 2020 and 2021 were years of rapid innovation and deployment of new health care technologies and delivery...
View Details
Keywords:
by HBS News
- 02 Sep 2014
- First Look
First Look: September 2
Harvard Business School Case 514-074 Sanofi Pasteur: The Dengue Vaccine Dilemma In 2012, Sanofi Pasteur was racing to develop a vaccine against dengue, a mosquito-borne disease, and was evaluating this...
View Details
Keywords:
Sean Silverthorne
- 06 May 2019
- Research & Ideas
Consumers Blame Business for Global Health Problems. Can Business Become the Solution?
to appeal to young would-be smokers. But corporate distrust runs so deep for some consumers that constructive dialogue is virtually impossible; consider vaccination skeptics who criticize Big Pharma’s influence, despite considerable...
View Details
- 29 Oct 2020
- Research & Ideas
The COVID Gender Gap: Why Fewer Women Are Dying
team also conducted surveys in the summer and fall that haven't yet been analyzed. "We're all adjusting to the pandemic in a rapid way, and there's a lot of uncertainty about what will come next—whether we'll see a strong second wave and where treatments and View Details
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
crops that have been engineered to have higher medicinal value. An "apple a day," in other words, would do more than keep the doctor away—it could replace the painful prick of a vaccination needle. And as "delivery...
View Details
- 25 Oct 2004
- Research & Ideas
Planning for Surprises
still awaits. We stick by our recommendation: Use your miles! Q: What other looming, predictable surprises have you noticed since the book manuscript was completed? A: The flu vaccine crisis is a classic example of a predictable surprise....
View Details
Keywords:
by Martha Lagace
- 11 May 2020
- Op-Ed
Immigration Policies Threaten American Competitiveness
It is no secret that immigration has reshaped American innovation. Immigrants are the backbone of America’s most innovative industries, provide a quarter of our patent applications, and are numerous among our science and engineering superstars. Taken from World...
View Details
Keywords:
by William R. Kerr
- 17 Feb 2021
- Research & Ideas
Pandemic Self-Care for CEOs: Rituals, Running, and Cognitive Restructuring
which a successful vaccine was developed; and the inherent sense of rebirth and freedom that comes with spring blend into a potent psychological cocktail. All of these things are, of course, legitimate cause for celebration and...
View Details
- 17 Dec 2020
- Research & Ideas
The 10 Most Popular Stories of 2020
reader interest in an interview with Merck CEO Ken Frazier, who talked candidly about prospects for COVID-19 vaccines and racism in the workplace. Here are our most popular articles, research papers, and social media posts of 2020. In the...
View Details
Keywords:
by Dina Gerdeman
- 22 Mar 2016
- First Look
March 22, 2016
Vaccinations Evive Health is a company that manages communication campaigns on behalf of health insurance plans and large employers. Using big data techniques and insights from behavioral economics, Evive deploys targeted and effective...
View Details
Keywords:
Sean Silverthorne
- 01 Jun 2009
- Lessons from the Classroom
The Challenges of Investing in Science-Based Innovation
she adds, with the development of a vaccine against cervical cancer (Gardasil) and the launch of successful new drugs to combat diabetes and HIV/AIDS. Sato acknowledges that different situations will require different business...
View Details